Vanguard Group Inc's 13G/A Filing for TuHURA Biosciences Inc

The Vanguard Group Inc filed an amendment (Schedule 13G/A) to its ownership report for TuHURA Biosciences Inc, disclosing ownership of 2,269,666 shares, representing 4.44% of the company's common stock. The filing indicates that Vanguard holds these shares on behalf of its clients, including investment companies and managed accounts. The shares are held in the ordinary course of business and not for the purpose of influencing control of the issuer. The filing also notes that no single client owns more than 5% of the shares. The amendment was signed by Ashley Grim, Head of Global Fund Administration, on October 31, 2025.